BiotechTube

Phenazopyridine Hydrochloride + Placebo

Phase 3Completed
0 watching 0 views this week📈 Rising
72
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Pain

Conditions

Pain, Urinary Tract Infections

Trial Timeline

Dec 1, 2009 → Dec 1, 2010

NCT ID
NCT01064024

About Phenazopyridine Hydrochloride + Placebo

Phenazopyridine Hydrochloride + Placebo is a phase 3 stage product being developed by Amneal Pharmaceuticals for Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT01064024. Target conditions include Pain, Urinary Tract Infections.

Hype Score Breakdown

Clinical
27
Activity
18
Company
5
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT01064024Phase 3Completed

Competing Products

20 competing products in Pain

See all competitors
ProductCompanyStageHype Score
PRF110- oily solution (Ropivacaine)PainReformPhase 2
44
PRF110PainReformPhase 2
44
PRF-108 + Placebo + Ropivacaine + PRF-110PainReformPhase 1/2
33
TRV130 1.5 mg + TRV130 3 mg + TRV130 4.5 mg + Morphine 10 mg + PlaceboTrevenaPhase 1
25
Oliceridine + Placebo + MorphineTrevenaPhase 3
69
Oliceridine + Placebo + MorphineTrevenaPhase 3
69
TRV130TrevenaPhase 3
69
TRV130 + Morphine + PlaceboTrevenaPhase 2
44
TRV130TrevenaPhase 2
44
LY3556050 + PlaceboEli LillyPhase 2
52
Popliteal nerve block including liposomal bupivacaine + Adductor canal nerve block including liposomal bupivacaine + Continuous popliteal nerve block with normal saline + Popliteal nerve block with exclusively unencapsulated bupivacaine + Adductor canal nerve block with exclusively unencapsulated bupivacaine + Continuous popliteal nerve block with unencapsulated bupivacainePacira BiosciencesApproved
80
Nanoformed Piroxicam IR Tablet + Felden (piroxicam) Tablets + Brexidol (piroxicam) TabletsNanoform FinlandPhase 1
28
0.75% bupivacaine + .75% bupivacaine + .75% bupivacaineSI-BONEApproved
77
LY3526318 + PlaceboEli LillyPhase 2
52
LY3857210 + PlaceboEli LillyPhase 2
52
OK-101 0.05% + OK-101 0.1% + PlaceboOKYO PharmaPhase 2
44
YHD1119 + LyricaYuhanPhase 1
33
YHD1119 + LyricaYuhanPhase 1
33
YHD1119 + LyricaYuhanPhase 3
77
YHD1119 300mg + YHD1119 300mgYuhanPhase 1
33

Other Products from Amneal Pharmaceuticals

CREXONT ERApproved
80
CREXONT ERApproved
80
Testosterone Topical Gel, 1.62% Metered Pump + AndroGel (testosterone gel) 1.62% Metered-Dose PumpPhase 3
72
Diclofenac Sodium Topical Gel, 1% + Voltaren Topical Gel, 1% + Vehicle Diclofenac Sodium Topical GelPhase 3
72
Placebo of Phenazopyridine Hydrochloride Tables, USP 200 mg + Phenazopyridine Hydrochloride Tables, USP 200 mgPhase 3
72